Concepedia

Michaela Mattheus

MM

49

Publications

19.2K

Citations

31

H-Index

2011

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Toronto

Lunenfeld-Tanenbaum Research Institute

Yale University

Mount Sinai Hospital

Michaela Mattheus is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2011–2024

49

Publications

49

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 11.6K citations · Full text

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen et al. · JAMA · 2019 · 578 citations · Full text

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

Christoph Wanner, John M. Lachin, Silvio E. Inzucchi et al. · Circulation · 2017 · 462 citations · Full text

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

David Z.I. Cherney, Bernard Zinman, Silvio E. Inzucchi et al. · The Lancet Diabetes & Endocrinology · 2017 · 363 citations

, , +10

Rows per page

1–5 of 49